High-grade Ta/ T1 Papillary Disease Bladder Cancer
specificAn invasive or non-invasive papillary urothelial carcinoma of the urinary bladder. It is classified as low or high-grade.
9
Centers
9
Active Trials
—
Cancer Funding
Top Centers for High-grade Ta/ T1 Papillary Disease Bladder Cancer(9)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 55.6 |
| 2 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 55.6 |
| 3 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 55.6 |
| 4 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 55.6 |
| 5 | Boston University Cancer CenterBoston, MA Active Research Program | 55.6 |
| 6 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 55.6 |
| 7 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 55.6 |
| 8 | Active Research Program | 55.6 |
| 9 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 55.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →